Etoposide (ETO), a popular anticancer drug that inhibits topoisomerase II enzymes, may be
administered more effectively and efficiently due to nanomedicine. The therapeutic …

Glioblastoma (GBM) is a particularly aggressive brain cancer associated with high
recurrence and poor prognosis. The standard of care, surgical resection followed by …

Glioblastoma (GBM) is the most common malignant adult brain cancer with no curative
treatment strategy. A significant hurdle in GBM treatment is effective therapeutic delivery to …

Currently, there are no viable curative treatments that can enhance the central nervous
system's (CNS) recovery from trauma or illness. Bioengineered injectable smart/stimuli …

Glioblastoma multiforme (GBM) is an aggressive brain tumor with high mortality rates. Due to
its invasiveness, heterogeneity, and incomplete resection, the treatment is very challenging …

Chemotherapy and radiation remain as mainstays in the treatment of a variety of cancers
globally, yet some therapies exhibit limited specificity and result in harsh side effects in …

Despite the emergence of cutting-edge therapeutic strategies and tremendous progress in
research, a complete cure of glioma remains elusive. The heterogenous nature of tumor …

Polymeric hydrogels have extraordinary potential to be utilized for biomedical applications.
Recently, sprayable hydrogels have received increasing attention for their biocompatibility …

Recent literature concerning the use of polymer and ceramic coatings for a variety of
biomedical applications is surveyed in this review. Applications have been grouped into six …

We investigated how the biodistribution of cannabidiol (CBD) within the central nervous
system (CNS) is influenced by two different formulations, an oil-in-water (O/W) …